Because much cancer research and clinical trials have been based on white populations, efforts to explore the ways race and ethnicity influence disease are underway.
By Emma Goldberg Sept. 11, 2020
The Genome Center’s two-year-old initiative, called Polyethnic-1000, is aimed at closing the knowledge gap that exists largely because decades of genetic studies focused mainly on white patient populations. Read more HERE.
Total Page Visits: 1375 - Today Page Visits: 1